Randall Bateman, MD, and David Holtzman, MD, are joint recipients of the 2026 WashU Medicine Dean's Medal for Excellence in Innovation & Commercialization, honoring their field-transforming translational work in Alzheimer's disease diagnosis and treatment. https://bit.ly/456UXEO

Congratulations to Baback Arshi, MD, who received the Barnes-Jewish Hopsital Connect Award! His compassionate willingness to go above and beyond have made a lasting impact on patients and families. One family shared that Arshi doesn’t just treat patients, he treats people.

Non-invasive neuromodulation technology has received FDA Breakthrough Device Designation. A clinical trial led by Jin-Moo Lee, MD, PhD, & Osvaldo Laurido-Soto, MD, linked non-invasive ear stimulation with lower inflammatory markers in some stroke patients. https://bit.ly/4w8Hl7W

WashU Medicine Neurology has been designated a CurePSP Center of Care! We are so proud to provide comprehensive, high-quality clinical care for our patients diagnosed with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) or multiple system atrophy (MSA).

Flashing back to our vascular neurology fellowship graduation dinner. We wish them the best in their future endeavors!

Our very own Stacey Krueger, MSW, LCSW, helped coordinate a concert fundraiser benefitting the Missouri chapter of the @hdsanational.bsky.social. At one point during the concert, a board member led the crowd in singing Woody Guthrie’s "This Land is Your Land."

Congratulations to Sarah Bauer Huang, MD, PhD, who was elected into the Child Neurological Society as a 2026 fellow! https://bit.ly/4fCvidh

Timothy Miller, MD, PhD, has been awarded the 2026 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases for his pioneering work in dementia. The Potamkin is one of the most prestigious international honors in dementia research. https://bit.ly/4vAorps

We are so excited to announce that 71 of our faculty were selected for the 2026 Castle Connolly Top Doctor's List! Designation as a "Top Doctor" highlights a provider's excellence in patient care. https://bit.ly/4wKA5ir

Don't forget to join Yo-El Ju, MD, and the American Heart Association on Tuesday, July 21 to discuss sleep health as part of the AHA's "Unlocking the Power of Sleep to Advance Heart & Brain Health" webinar. Register to attend! https://bit.ly/4w63l2X

The University of Rochester Medicine selected John Morris, MD, as the 2026 School of Medicine & Dentistry Distinguished Alumnus Award recipient! The recognition is presented to an alumnus who "exemplifies the standards and objectives of the School of Medicine & Dentistry."

Congratulations to Stefanie Geisler, MD, who presented on chemotherapy-induced peripheral neuropathy & chaired a scientific session at the 2026 Meeting of the Peripheral Nerve Society. The meeting brings together scientists & clinicians from around the world. #PNS2026

Welcome to our newest fellows and residents! We are so proud that you have chosen WashU Medicine Neurology for your training.

ICYMI: Timothy Miller, MD, PhD, spoke to @stlmag.bsky.social about his work on tofersen, a treatment for a genetic form of ALS. "Washington University is an incredible environment to do neurodegenerative disease research." Read the article and listen to The 314 Podcast now: https://bit.ly/4ecTfGi

New research from Nico Dosenbach, MD, PhD, and colleagues published in @science.org found that socioeconomic status is one of the biggest factors impacting the development of kids' brains — more than even IQ, parenting style or health history. Read more: https://bit.ly/4eelc1K

A new article in Muscle & Nerve from Sean E. Smith, MD, MPHS, and colleagues found that integrating neuromuscular rehabilitation (NMR) with tofersen enables clinical stabilization and partial functional recovery in some individuals with SOD1 ALS for more than 3 years. https://bit.ly/4eY7Qqt

Meet our 2026-27 Neurology Residency Program chief residents! They started their official positions earlier this week (though they truly have been doing the job for weeks). We look forward to seeing you continue to grow as leaders this year.

Happy July 1 to all those who celebrate! WashU Medicine Neurology welcomes all new faculty, fellows, residents and students who are joining our team today. Stay tuned to meet them in future posts!

A new study in Nature Medicine co-authored by Daniel Di Luca, MD, MSc, found that combining skin tests and a blood test may help doctors better tell apart Parkinson’s disease, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). https://go.nature.com/4vLzixo

Randall Bateman, MD, & David Holtzman, MD, received the 2026 American Innovator Award from the Bayh-Dole Coalition. It honors their decades of work that has transformed Alzheimer's disease diagnosis. https://medicine.washu.edu/news/bateman-and-holtzman-receive-2026-american-innovator-award/

Congratulations to Renée Shellhaas, MD, MS, who was installed as the David T. Blasingame Professor of Neurology earlier this month! The professorship was created in 2019 to honor the contributions of David T. Blasingame, who led University Advancement for 28 years. https://bit.ly/4e1cQKF

For today’s #GrandRounds, Pooja Khatri, MD, MSc, chair of neurology @yaleschoolofmed.bsky.social, gave the 40th Irwin Levy Lecture, looking back on 20 years of clinical trials and therapeutics development for acute stroke and highlighting important new directions for the field.

ICYMI: Our Division of Pediatric Neurology represented #WashUMedicine well at the International Pediatric Stroke Organization (IPSO) annual conference last month.

In today’s #GrandRounds, Benjamin P. Kay, MD, PhD, showed how fMRI and other imaging modalities can give scientists a more accurate understanding of conditions such as ADHD, making it possible to develop personalized and targeted treatments and assess their effectiveness.

Suzanne Schindler, MD, PhD, and Christopher Smyser, MD, were two of three WashU Medicine faculty recently elected to the American Society for Clinical Investigation (ASCI)! It is one of the U.S.'s oldest and most respected medical honor societies. https://bit.ly/3R1Cd61

Tofersen, a treatment for a genetic form of ALS developed by Timothy Miller, MD, PhD, and colleagues, changed Amanda Sifford's life. It has the potential to stop or even reserve some symptoms. Check out @nytimes's feature article: https://nyti.ms/4d3Dnqb

The LGMD2D Foundation has gifted $50,000 to WashU Medicine Neurology to advance research led by Conrad Weihl, MD, PhD, focused on SGCA variants, precision therapeutics. We’re proud to collaborate w/ patient advocacy groups who share our commitment to innovation & hope for the communities we serve.

Timothy Miller, MD, PhD, and Jin-Moo Lee, MD, PhD, were both elected to the Association of American Physicians. The honorary society fosters physician-led scientific discovery to improve patient care and public health. https://bit.ly/4uVXgpw

In today’s #GrandRounds, resident-invited speaker Alyx B. Porter Umphrey, MD, from the @mayoclinic, discussed the importance of creating accessible and comprehensive pathways to improve representation in medicine for the benefit of all.

Congratulations to Joyce Balls-Berry, PhD, who recently received a 2026 Fellows of Association for Clinical and Translational Science (ACTS) Award! This recognition acknowledges individuals for their lasting impact to clinical and translational science. https://bit.ly/42AotSt